IXHL
Incannex Healthcare Inc.Company Information
- Company Name
- Incannex Healthcare Inc.
- CIK
- CIK0001873875
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- IXHL: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IXHL
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 454,684
- Shares outstanding
- 12,348,460
- Ownership
- 3.68%
Earnings Market Reaction
- Filing date
- 2026-09-25
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 68 | 74 | 69 | 73 | 15 | 7 | 2 | 4 | 6 | 9 | 15 | ||||||
| Restricted Cash Current | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 7 | 7 | ||||||
| Other Receivables Net Current | 5 | 5 | 5 | 5 | 4 | 7 | 7 | 11 | 10 | - | - | ||||||
| Assets Current | 73 | 80 | 75 | 78 | 20 | 16 | 11 | 15 | 16 | 16 | 21 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | - | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 73 | 80 | 75 | 79 | 20 | 16 | 11 | 16 | 17 | 17 | 22 | ||||||
Liabilities Current | |||||||||||||||||
| Accounts Payable Other Current | - | - | - | - | - | - | - | - | 1 | 1 | 2 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 2 | 1 | 1 | 6 | 1 | 1 | 2 | 1 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 0 | 1 | 5 | 3 | 7 | 5 | - | - | ||||||
| Short Term Borrowings | - | - | - | - | - | 1 | 1 | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 1 | 2 | 2 | 2 | 7 | 7 | 6 | 9 | 6 | 3 | 3 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | 2 | - | - | - | - | ||||||
| Warrants And Rights Outstanding | - | 3 | - | - | - | 1 | 1 | - | - | - | - | ||||||
| Liabilities | 6 | 5 | 2 | 2 | 7 | 9 | 10 | 9 | 6 | 3 | 3 | ||||||
Stockholders Equity | |||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 248 | 253 | 247 | 244 | 174 | 137 | 126 | 126 | 125 | 122 | 120 | ||||||
| Retained Earnings Accumulated Deficit | -177 | -174 | -170 | -164 | -158 | -126 | -122 | -116 | -111 | -104 | -98 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -4 | -4 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -4 | -3 | ||||||
| Stockholders Equity | 67 | 75 | 73 | 77 | 13 | 7 | 1 | 7 | 11 | 14 | 19 | ||||||
| Liabilities And Stockholders Equity | 73 | 80 | 75 | 79 | 20 | 16 | 11 | 16 | 17 | 17 | 22 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 800 | 800 | 800 | 800 | 800 | 100 | 100 | 100 | 800 | 100 | 100 | ||||||
| Common Stock Shares Issued | 13 | 14 | 12 | 12 | 6 | 12 | 1 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 13 | 14 | 12 | 12 | 6 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIncannex Healthcare Inc. (IXHL) — SEC Financial Statements & Analysis
Incannex Healthcare Inc. (IXHL) is a pharmaceutical preparations company, incorporated in DE. Incannex Healthcare Inc. trades on Nasdaq as: IXHL. Incannex Healthcare Inc. (IXHL)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-25. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Incannex Healthcare Inc. carries a market cap of $43.84M, a P/E ratio of -2.27x, a P/B ratio of 0.65x, a P/S ratio of -430.76x, an enterprise value of $-23.88M, and an EV/EBITDA multiple of 1.05x. On profitability, it posts an operating margin of 29494.19%, a net margin of 56295.35%, a Return on Equity (ROE) of -47.80%, a Return on Assets (ROA) of -41.32%, and a Return on Invested Capital (ROIC) of -1764.69%. Per share, it reports EPS of $-1.66, diluted EPS of $-1.66, free cash flow per share of $-1.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -58.83% year-over-year, and EPS growth of -95.94% year-over-year. On the balance sheet, it maintains a current ratio of 48.81x, a quick ratio of 48.45x, working capital of $71.33M, a debt-to-equity ratio of 0.08x, a debt ratio of 0.08, an interest coverage ratio of -1439.19x, free cash flow of $-12.88M (TTM), and net debt of $-67.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $43.84M
- P/E TTM
- -2.27x
- EPS TTM
- $-1.66
- P/B TTM
- 0.65x
- ROE TTM
- -47.80%
- ROA TTM
- -41.32%
- Debt To Equity
- 0.08x
- Free Cash Flow TTM
- $-12.88M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Incannex Healthcare Inc. in?
Incannex Healthcare Inc. (IXHL) operates in the Pharmaceutical Preparations industry.
What exchange does IXHL trade on?
Incannex Healthcare Inc. (IXHL) trades on the Nasdaq.
Where is Incannex Healthcare Inc. incorporated?
Incannex Healthcare Inc. is incorporated in DE.
When was Incannex Healthcare Inc. (IXHL)'s most recent SEC filing?
Incannex Healthcare Inc. (IXHL)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-25.
What is IXHL's market cap?
Incannex Healthcare Inc. (IXHL) has a market capitalization of $43.84M as of 2026-06-30.
What is IXHL's EPS (earnings per share)?
Incannex Healthcare Inc. (IXHL)'s trailing twelve month EPS is $-1.66 as of 2026-06-30.
What is IXHL's ROE (return on equity)?
Incannex Healthcare Inc. (IXHL)'s trailing twelve month Return on Equity (ROE) is -47.80% as of 2026-06-30.
What is IXHL's ROA (return on assets)?
Incannex Healthcare Inc. (IXHL)'s trailing twelve month Return on Assets (ROA) is -41.32% as of 2026-06-30.
What is IXHL's ROIC (return on invested capital)?
Incannex Healthcare Inc. (IXHL)'s trailing twelve month Return on Invested Capital (ROIC) is -1764.69% as of 2026-03-31.
What is IXHL's EV/EBITDA?
Incannex Healthcare Inc. (IXHL)'s trailing twelve month EV/EBITDA is 1.05x as of 2026-06-30.